Related Experiment Videos
Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+
Abstract:
The ability of astrocytes to convert 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) to its toxic metabolite 1-methyl-4-phenylpyridinium ion (MPP+) was directly tested. Cultured astrocytes rapidly converted MPTP (25 micrograms/ml) to MPP+; after 6 h MPP+ concentrations reached 1.5 micrograms/ml, within the toxic range for neurons. MPTP (above 10 micrograms/ml) reduced glial density after 5 days of exposure. This toxic effect was blocked by pargyline, a monoamine oxidase inhibitor; pargyline also reduced the conversion of MPTP to MPP+ by 85%. When neurons were added to astrocyte cultures, MPTP conversion to MPP+ was not enhanced. Astrocytes appear critical in converting MPTP to MPP+, and are damaged by chronic exposure to MPTP.
Insights
Astrocytes convert 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into its toxic form, MPP+. Chronic MPTP exposure damages astrocytes, but this neurotoxic effect can be mitigated by monoamine oxidase inhibitors.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin implicated in Parkinsonism.
- Astrocytes play crucial roles in central nervous system homeostasis and neuronal support.
Purpose of the Study:
- To investigate the role of astrocytes in the metabolism of MPTP.
- To determine the direct toxic effects of MPTP on astrocytes.
Main Methods:
- Primary astrocyte cultures were exposed to MPTP.
- MPP+ concentrations were measured using analytical techniques.
- Glial density was assessed after MPTP exposure.
- The effect of pargyline, a monoamine oxidase inhibitor, was evaluated.
Main Results:
- Cultured astrocytes efficiently converted MPTP to MPP+ within toxic ranges for neurons.
- MPTP exposure reduced glial density, indicating astrocyte toxicity.
- Pargyline inhibited MPTP to MPP+ conversion by 85% and blocked MPTP's toxic effects on glial density.
- Co-culturing with neurons did not enhance MPTP conversion by astrocytes.
Conclusions:
- Astrocytes are critical in metabolizing MPTP to its toxic MPP+ form.
- Astrocytes are susceptible to damage from chronic MPTP exposure.
- Monoamine oxidase inhibitors can protect astrocytes from MPTP-induced toxicity.